Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,144.28
    +65.42 (+0.81%)
     
  • Bitcoin USD

    63,396.83
    -464.65 (-0.73%)
     
  • CMC Crypto 200

    1,324.38
    -72.15 (-5.17%)
     
  • S&P 500

    5,098.19
    +49.77 (+0.99%)
     
  • Dow

    38,199.08
    +113.28 (+0.30%)
     
  • Nasdaq

    15,915.78
    +304.02 (+1.95%)
     
  • Gold

    2,345.20
    +2.70 (+0.12%)
     
  • Crude Oil

    84.06
    +0.49 (+0.59%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Here's Why Incyte Rose 19.1% in the First Half of 2020

Here's Why Incyte Rose 19.1% in the First Half of 2020

Shares of Incyte (NASDAQ: INCY) rose more than 19% in the first six months of the year, according to data provided by S&P Global Market Intelligence. After struggling to commercialize pipeline assets in recent years and diversify revenue away from Jakafi, Incyte appears to be making tangible progress with its late-stage pipeline. Wall Street appears a little more willing to buy into the company's growth pitch, which rests on a solid foundation provided by the Jakafi franchise.